The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung CancerMisako Nagasaka, Stephen V. Liu, Vijendra K. Singh et al.|Clinical Lung Cancer|2021Cited by 30
Genomic landscape and immune phenotype of malignant pleural mesothelioma.Meera Patel, Hirva Mamdani, Andrew Elliott et al.|Journal of Clinical Oncology|2020Cited by 6
Characterization of KRAS mutations (mt) in non-small cell lung cancer (NSCLC).Stephen V. Liu, Hossein Borghaei, Ari M. Vanderwalde et al.|Journal of Clinical Oncology|2020Cited by 5
Characterization of ERBB2 alterations in non-small cell lung cancer.Vijendra K. Singh, Misako Nagasaka, Rebecca Feldman et al.|Journal of Clinical Oncology|2020Cited by 4
P76.43 Co-occurring genomic alterations and treatment outcomes in patients with EGFR exon 20 insertion positive NSCLCC. Kim, Ari M. Vanderwalde, Luis E. Raez et al.|Journal of Thoracic Oncology|2021Cited by 2